Kandy Therapeutics Limited
Records under this name other than the patents Kandy Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 3 of 3 · Back to Kandy Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,683,056 | Pyridine Derivatives and Their Use in the Treatment of Psychotic Disorders Term ended Term ended Sep 15, 2026 · High confidence | Term ended | Term ended Sep 15, 2026 | High confidence |
| US 7,919,491 | Pyridine derivatives and their use in the treatment of psychotic disorders Term ended Term ended Sep 7, 2026 · USPTO record | Term ended | Term ended Sep 7, 2026 | USPTO record |
| US 8,097,618 | Pyridine derivatives and their use in the treatment of psychotic disorders Term ended Term ended Sep 7, 2026 · USPTO record | Term ended | Term ended Sep 7, 2026 | USPTO record |